Instruction for use: Klimadynon

Active substance Tsimitsifugi racemose rhizomes with roots extract

ATX code G02CX Preparations for the treatment of gynecological diseases others

Pharmacological groups

Estrogens, gestagens; Their homologues and antagonists

Nosological classification (ICD-10)

E28.8 Other types of ovarian dysfunction

N95.1 menopausal and menopausal status of women

Atrophy of the mucosa of the lower genital tract, caused by estrogen deficiency; Vaginal dryness; Autonomic dysfunction in women; gipoestrogeniya state; Deficiency of estrogen in menopausal women; Degenerative changes of the mucous membrane in the menopause; Natural menopause; an intact uterus; climacteric; Menopause women; Menopause in women; menopausal depression; Climacteric ovarian dysfunction; Menopause; Climacteric neurosis; Menopause; Menopausal symptoms complicated psychovegetative; Climacteric syndrome; Climacteric vegetative disorders; Climacteric psychosomatic disorder; menopausal disorders; Menopausal disorders in women; menopausal condition; Climacteric vascular disorders; Menopause; Menopausal vasomotor symptoms; menopausal period; Lack of estrogen; Feeling the heat; Pathological menopause; perimenopause; menopause; postmenopausal; Premature menopause; premenopauznom period; tides; hot flashes; flushing in the Meno and postmenopausal; Hot flashes / hot flashes in menopause; Heart attack during menopause; Early menopause in women; Disorders of menopause; climacteric syndrome; Vascular complications of menopause; Physiological menopause; Estrogendefitsitnye state; premature Menopause

Composition

Tablets, coated with a coating.

active substance:

Tsimicifuga (Cimicifuga racemosa L.) rhizomes extract dry 20 mg

(Contains 2.8 mg tsimicifuga rhizome extract native (5-10: 1, extractant - ethanol 58 vol.%) And 17.2 mg lactose monohydrate)

Auxiliary substances: calcium hydrophosphate dihydrate; potato starch; Magnesium stearate; talc; Titanium dioxide (E171); Iron oxide yellow (E172); Iron oxide red (E172); Macrogol 6000; Eudragit RL 30D (ammonium methacrylate copolymer (1: 2: 0.2) - 1.35 mg and sorbic acid 0.01 mg)

Drops for ingestion 100 g

active substance:

Tsimicifuga (Cimicifuga rhizome) rhizome extract liquid 12 g

(Corresponding to 2.4 g of dried medicinal plant material)

Auxiliary substances: sodium saccharinate dihydrate; Mint pepper oil; Ethanol 96% by volume; purified water

The ethanol content is 35-40 vol.%

Description of dosage form

Tablets: round, biconvex, covered with a pink color with a brown tint.

Drops for oral administration: clear liquid of light brown color, with the smell of wood; In the course of storage, slight turbidity or precipitation of a slight precipitate is possible.

pharmachologic effect

The pharmacological action is estrogen-like, antiplasmic.

Pharmacodynamics

Has an estrogen-like effect, shows sedative properties, has a therapeutic effect on the autonomic nervous system. The use of the drug contributes to the weakening or complete disappearance of the symptoms of malaise in the climacteric period. The therapeutic effect develops gradually and manifests itself after about 2 weeks of treatment.

Indications for Kimadynon®

Vegeto-vascular disorders in the period of menopause, pre- and postmenopausal (hot flashes, excessive sweating, sleep disturbances, increased nervous excitability, mood changes, apathy).

Contraindications

For drops and tablets:

Hypersensitivity;

Estrogen-dependent tumors.

With caution: liver disease, epilepsy, diseases and brain trauma (use is possible only after consulting a doctor).

Additionally for drops: alcoholism.

Additionally for coated tablets: lactose intolerance.

pregnancy and lactation

Do not use when you are pregnant.

Side effects

Allergic reactions are possible. In rare cases, there may be pain in the epigastric region, an increase in body weight. Very rarely - the appearance of a feeling of tension in the mammary glands and menstrual like bleeding.

Interaction

Interactions with other drugs are currently unknown.

Dosing and Administration

Inside.

Take 30 drops or 1 table. (Not taking a snap, squeezed a small amount of liquid) 2 times a day (in the morning and in the evening, at the same time).

The duration of treatment is determined by the doctor.

Overdose

Cases of overdose and intoxication are currently unknown.

special instructions

Without consulting a doctor, the drug should not be taken more than 3 months.

When used in recommended doses, the drug does not affect the reaction rate when driving vehicles and mechanisms.

When pregnancy occurs, stop taking the drug and consult a doctor.

In the composition of drops for oral administration contains 35-40 vol.% Ethanol.

When using the bottle, keep it in a vertical position.

During the storage of drops, there may be a slight precipitation or slight turbidity, which does not affect the effectiveness of the drug.

Drops for oral administration should be shaken before use.

Indication for patients with diabetes. Patients with diabetes can take Kimadynon ® tablets because A single dose of this drug contains less than 0.04 XE.

Form of issue

The tablets covered with a cover. In aluminum foil blisters (bottom side) and PVC (polyvinyl chloride) / PE (polyethylene) / PVDC (polyvinylidene chloride) films (top side) 15 pcs. Each. In a pack of cardboard 4 or 6 blisters.

Drops for oral administration. In bottles of dark glass with a dispensing drip device on top, with a screw cap, a safety ring, 50 or 100 ml. Each vial is in a folding carton box.

Terms of leave from pharmacies

Without recipe.

Storage conditions

In dry, the dark place at a temperature of no higher than 25 ° C.

Keep out of the reach of children.

Shelf Life of Kimadynon®

3 years.

Do not use after the expiry date printed on the package.